imatinib mesylate has been researched along with Nail Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Chaturvedi, A; Thapa, M | 1 |
| Dogra, S; Handa, S; Khadwal, A; Kumari, S; Lad, D; Malhotra, P; Prakash, G; Suri, V; Varma, S; Vinay, K; Yanamandra, U | 1 |
| Barisani, A; Dika, E; Fanti, PA; Ismaili, A; Patrizi, A; Vaccari, S | 1 |
| Lam, YK; Lau, YM; Leung, KH; Lin, SY | 1 |
| Ambrifi, M; Bottoni, U; Calvieri, S; Clerico, R; Corsetti, P; Didona, D; Paolino, G | 1 |
| Ergun, T; Eser, A; Kaygusuz Atagunduz, I; Salman, A | 1 |
| Benabbes, M; Meddah, B; Tazi Mezalek, Z | 1 |
| Bienz, N; Dickens, E; Lewis, F | 1 |
| Asano, Y; Hatano, M; Kawashima, T; Kinugawa, K; Nagai, R; Sato, S; Tamaki, Z; Tomita, M; Yao, A | 1 |
| Field, EA; Rajlawat, BP; Steele, JC; Triantafyllou, A | 1 |
| Armand, JP; Boige, V; Escudier, B; Le Cesne, A; Le Chevalier, T; Lhomme, C; Malka, D; Pautier, P; Robert, C; Soria, JC; Spatz, A; Wechsler, J | 1 |
| Deguchi, N; Kawamura, T; Kitamura, R; Matsue, H; Shibagaki, N; Shimada, S; Shimizu, A; Yanagi, M | 1 |
| Burgin, S; Heidary, N; Naik, H | 1 |
2 review(s) available for imatinib mesylate and Nail Diseases
| Article | Year |
|---|---|
Cutaneous side-effects of kinase inhibitors and blocking antibodies.
Topics: Antibodies, Blocking; Antineoplastic Agents; Benzamides; Benzenesulfonates; ErbB Receptors; Hair Diseases; Humans; Imatinib Mesylate; Nail Diseases; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Skin Diseases; Sorafenib | 2005 |
Chemotherapeutic agents and the skin: An update.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites; Antineoplastic Agents; Benzamides; Benzenesulfonates; Cetuximab; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; ErbB Receptors; Erlotinib Hydrochloride; Fusion Proteins, bcr-abl; Gefitinib; Hair Diseases; Humans; Imatinib Mesylate; Indoles; Mucous Membrane; Nail Diseases; Niacinamide; Phenylurea Compounds; Piperazines; Platinum Compounds; Proteasome Inhibitors; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Signal Transduction; Skin; Skin Diseases; Sorafenib; Sunitinib; Taxoids | 2008 |
11 other study(ies) available for imatinib mesylate and Nail Diseases
| Article | Year |
|---|---|
Imatinib-induced melanonychia in a patient of chronic myeloid leukaemia: rarely reported side effect.
Topics: Adult; Antineoplastic Agents; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nail Diseases; Pigmentation Disorders | 2020 |
Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Cross-Sectional Studies; Drug Eruptions; Edema; Eye Diseases; Female; Humans; Hyperpigmentation; Hypopigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Nail Diseases; Sex Factors; Skin Diseases, Vesiculobullous; Time Factors; Young Adult | 2018 |
Periungual pyogenic granuloma following imatinib therapy in a patient with chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Benzamides; Female; Granuloma, Pyogenic; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Nail Diseases; Piperazines; Pyrimidines | 2013 |
Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate.
Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Nail Diseases; Piperazines; Pyrimidines | 2014 |
Skin lesions in patients treated with imatinib mesylate: a 5-year prospective study.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Dermatitis, Seborrheic; Dermatomycoses; Drug Eruptions; Eczema; Edema; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Histiocytoma, Benign Fibrous; Humans; Imatinib Mesylate; Keratosis, Actinic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nail Diseases; Orbital Diseases; Prospective Studies; Pruritus; Psoriasis; Skin Neoplasms | 2016 |
Horizontal melanonychia.
Topics: Aged, 80 and over; Antineoplastic Agents; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Melanosis; Nail Diseases; Nails, Malformed; Protein Kinase Inhibitors | 2017 |
A case report of rare palmoplantar keratosis and nail dystrophy with imatinib.
Topics: Antineoplastic Agents; Female; Foot; Hand; Humans; Imatinib Mesylate; Keratoderma, Palmoplantar; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Nail Diseases; Skin | 2017 |
Imatinib: a designer drug, another cutaneous complication.
Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nail Diseases; Piperazines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines | 2009 |
Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases.
Topics: Aged; Benzamides; Contracture; Dose-Response Relationship, Drug; Female; Hemorrhage; Humans; Imatinib Mesylate; Male; Middle Aged; Nail Diseases; Nails; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Range of Motion, Articular; Raynaud Disease; Scleroderma, Systemic; Skin; Treatment Outcome | 2012 |
Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib.
Topics: Antineoplastic Agents; Benzamides; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Nail Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2012 |
Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia.
Topics: Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Female; Humans; Imatinib Mesylate; Keratoderma, Palmoplantar; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nail Diseases; Piperazines; Pyrimidines | 2006 |